Martin A. Smith - 01 Sep 2023 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Executive Vice President
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Martin A. Smith
Issuer symbol
IDXX
Transactions as of
01 Sep 2023
Net transactions value
-$2,556
Form type
4
Filing time
06 Sep 2023, 17:01:13 UTC
Previous filing
16 Feb 2023
Next filing
16 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $0 +19 +9.2% $0.000000 226 01 Sep 2023 Direct F1
transaction IDXX Common Stock Tax liability $2,556 -5 -2.2% $511.29 221 01 Sep 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Restricted Stock Unit Options Exercise -19 -1% 1,827 01 Sep 2023 Common Stock 19 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes a total of 26.7030 shares purchased under the Issuer's Employee Stock Purchase Plan on March 31, 2023 and June 30, 2023.
F2 Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning September 1, 2022.
F3 Not applicable.